Discover 65 paid clinical trials in Jonesboro, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 65
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Jonesboro AR, Springfield MO, Chesterfield MO, Tyler TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
SELUTION4BTK Trial
for
Peripheral Arterial Disease,
Location: Jonesboro AR, Nashville TN, Tyler TX, Oklahoma City OK,
Sponsor: M.A. Med Alliance S.A.
Sex: All
Age: 18+
Code: NCT05055297
Recruiting
ViewFlex X ICE First-in-Human Study
for
Cardiac Arrhythmias
Location: Jonesboro AR, Kansas City MO, Houston TX,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06772493
Recruiting
New
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
for
Atrial Fibrillation
Location: Jonesboro AR, Austin TX, New York NY, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06099730
Recruiting
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for
Atrial Fibrillation
Location: Jonesboro AR, Lexington KY, Atlanta GA, Plano TX,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07523750
Recruiting
Agilis RF TSP Early Feasibility Study
for
Cardiac Arrythmias, Left Atrial Appendage Closure
Location: Jonesboro AR, Kansas City MO, San Francisco CA
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07361445
Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure